206 related articles for article (PubMed ID: 16000307)
21. Shc mediates IL-6 signaling by interacting with gp130 and Jak2 kinase.
Giordano V; De Falco G; Chiari R; Quinto I; Pelicci PG; Bartholomew L; Delmastro P; Gadina M; Scala G
J Immunol; 1997 May; 158(9):4097-103. PubMed ID: 9126968
[TBL] [Abstract][Full Text] [Related]
22. Different protein turnover of interleukin-6-type cytokine signalling components.
Siewert E; Müller-Esterl W; Starr R; Heinrich PC; Schaper F
Eur J Biochem; 1999 Oct; 265(1):251-7. PubMed ID: 10491180
[TBL] [Abstract][Full Text] [Related]
23. Identification of a 130-kilodalton tyrosine-phosphorylated protein induced by interleukin-11 as JAK2 tyrosine kinase, which associates with gp130 signal transducer.
Yin T; Yasukawa K; Taga T; Kishimoto T; Yang YC
Exp Hematol; 1994 May; 22(5):467-72. PubMed ID: 8174677
[TBL] [Abstract][Full Text] [Related]
24. Src directly tyrosine-phosphorylates STAT5 on its activation site and is involved in erythropoietin-induced signaling pathway.
Okutani Y; Kitanaka A; Tanaka T; Kamano H; Ohnishi H; Kubota Y; Ishida T; Takahara J
Oncogene; 2001 Oct; 20(45):6643-50. PubMed ID: 11641791
[TBL] [Abstract][Full Text] [Related]
25. Induction of gp130-related cytokines and activation of JAK2/STAT3 pathway in astrocytes precedes up-regulation of glial fibrillary acidic protein in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of neurodegeneration: key signaling pathway for astrogliosis in vivo?
Sriram K; Benkovic SA; Hebert MA; Miller DB; O'Callaghan JP
J Biol Chem; 2004 May; 279(19):19936-47. PubMed ID: 14996842
[TBL] [Abstract][Full Text] [Related]
26. Interleukin 6 inhibits proliferation and, in cooperation with an epidermal growth factor receptor autocrine loop, increases migration of T47D breast cancer cells.
Badache A; Hynes NE
Cancer Res; 2001 Jan; 61(1):383-91. PubMed ID: 11196191
[TBL] [Abstract][Full Text] [Related]
27. Flavanoids induce expression of the suppressor of cytokine signalling 3 (SOCS3) gene and suppress IL-6-activated signal transducer and activator of transcription 3 (STAT3) activation in vascular endothelial cells.
Wiejak J; Dunlop J; Mackay SP; Yarwood SJ
Biochem J; 2013 Sep; 454(2):283-93. PubMed ID: 23782265
[TBL] [Abstract][Full Text] [Related]
28. The comparative roles of suppressor of cytokine signaling-1 and -3 in the inhibition and desensitization of cytokine signaling.
Wormald S; Zhang JG; Krebs DL; Mielke LA; Silver J; Alexander WS; Speed TP; Nicola NA; Hilton DJ
J Biol Chem; 2006 Apr; 281(16):11135-43. PubMed ID: 16473883
[TBL] [Abstract][Full Text] [Related]
29. Tyrosine-phosphorylated SOCS-3 inhibits STAT activation but binds to p120 RasGAP and activates Ras.
Cacalano NA; Sanden D; Johnston JA
Nat Cell Biol; 2001 May; 3(5):460-5. PubMed ID: 11331873
[TBL] [Abstract][Full Text] [Related]
30. Contributions of leukemia inhibitory factor receptor and oncostatin M receptor to signal transduction in heterodimeric complexes with glycoprotein 130.
Hermanns HM; Radtke S; Haan C; Schmitz-Van de Leur H; Tavernier J; Heinrich PC; Behrmann I
J Immunol; 1999 Dec; 163(12):6651-8. PubMed ID: 10586060
[TBL] [Abstract][Full Text] [Related]
31. IL-6 triggers cell growth via the Ras-dependent mitogen-activated protein kinase cascade.
Ogata A; Chauhan D; Teoh G; Treon SP; Urashima M; Schlossman RL; Anderson KC
J Immunol; 1997 Sep; 159(5):2212-21. PubMed ID: 9278309
[TBL] [Abstract][Full Text] [Related]
32. Activation of Fes tyrosine kinase by gp130, an interleukin-6 family cytokine signal transducer, and their association.
Matsuda T; Fukada T; Takahashi-Tezuka M; Okuyama Y; Fujitani Y; Hanazono Y; Hirai H; Hirano T
J Biol Chem; 1995 May; 270(19):11037-9. PubMed ID: 7538109
[TBL] [Abstract][Full Text] [Related]
33. Interaction of the growth hormone receptor with cytokine-induced Src homology domain 2 protein in rat adipocytes.
Du L; Frick GP; Tai LR; Yoshimura A; Goodman HM
Endocrinology; 2003 Mar; 144(3):868-76. PubMed ID: 12586763
[TBL] [Abstract][Full Text] [Related]
34. Src family kinase-independent signal transduction and gene induction by leukemia inhibitory factor.
Laszlo GS; Nathanson NM
J Biol Chem; 2003 Jul; 278(30):27750-7. PubMed ID: 12764151
[TBL] [Abstract][Full Text] [Related]
35. The JAK-inhibitor, JAB/SOCS-1 selectively inhibits cytokine-induced, but not v-Src induced JAK-STAT activation.
Iwamoto T; Senga T; Naito Y; Matsuda S; Miyake Y; Yoshimura A; Hamaguchi M
Oncogene; 2000 Sep; 19(41):4795-801. PubMed ID: 11032030
[TBL] [Abstract][Full Text] [Related]
36. The tyrosine 974 within the LIF-R-chain of the gp130/LIF-R heteromeric receptor complex mediates negative regulation of LIF signalling.
Clahsen T; Lehmann U; Stross C; Hermanns HM; Volkmer-Engert R; Schneider-Mergener J; Heinrich PC; Schaper F
Cell Signal; 2005 May; 17(5):559-69. PubMed ID: 15683731
[TBL] [Abstract][Full Text] [Related]
37. Suppressor of cytokine signaling 3 inhibits breast tumor kinase activation of STAT3.
Gao Y; Cimica V; Reich NC
J Biol Chem; 2012 Jun; 287(25):20904-12. PubMed ID: 22547065
[TBL] [Abstract][Full Text] [Related]
38. CpG-induced tyrosine phosphorylation occurs via a TLR9-independent mechanism and is required for cytokine secretion.
Sanjuan MA; Rao N; Lai KT; Gu Y; Sun S; Fuchs A; Fung-Leung WP; Colonna M; Karlsson L
J Cell Biol; 2006 Mar; 172(7):1057-68. PubMed ID: 16567503
[TBL] [Abstract][Full Text] [Related]
39. Activation of STAT3 by IL-6 and IL-10 in primary human macrophages is differentially modulated by suppressor of cytokine signaling 3.
Niemand C; Nimmesgern A; Haan S; Fischer P; Schaper F; Rossaint R; Heinrich PC; Müller-Newen G
J Immunol; 2003 Mar; 170(6):3263-72. PubMed ID: 12626585
[TBL] [Abstract][Full Text] [Related]
40. Epigenetic modification of SOCS-1 differentially regulates STAT3 activation in response to interleukin-6 receptor and epidermal growth factor receptor signaling through JAK and/or MEK in head and neck squamous cell carcinomas.
Lee TL; Yeh J; Van Waes C; Chen Z
Mol Cancer Ther; 2006 Jan; 5(1):8-19. PubMed ID: 16432158
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
